Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer
Clinical trial NCT01335958 · COMPLETED
Trial details
- NCT number
- NCT01335958
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2014-02-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.